Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.
Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).
Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.
Dendrite Clinical Systems’ innovative “Intellect Web” software has been chosen by an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as the platform on which the CoviDiab project will establish a Global Registry to collect new cases of diabetes in patients with COVID-19.
The United Kingdom National Bariatric Surgery Registry 3rd Report (2020)
-
Code:ISBN 978-1-9160207-2-6
Published by Dendrite Clinical Systems, in conjunction with the British Obesity and Metabolic Surgery Society (BOMSS), the third iteration of the National Bariatric Surgery Registry Report builds on the previous two and includes data on an additional 38,388 patients taking the overall total to 70,461 patients. The report demonstrates the safety and effectiveness of bariatric and metabolic surgery in the UK. The report uses data from the National Bariatric Surgery Registry (NBSR), a decade long research collaboration between BOMSS and Dendrite Clinical Systems. Key highlights of the publication include:
- Bariatric Surgery procedures produced excess weight loss at one year of 73.7% after One Anastomosis Gastric Bypasses and 71.3% after Roux-en-Y gastric bypass, which compares favourably against 61.5% with sleeve gastrectomy and 38.8% with gastric banding.
- The effectiveness of surgery also reveals that the prevalence of Type 2 diabetes mellitus was reduced from 30% to 14% in the first year after surgery.
- In-hospital mortality from bariatric and metabolic surgery was very low at 0.04%, which compares very favourably with internationally accepted figures.
